Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity
Loading...
Identifiers
ISSN: 0168-3659
E-ISSN: 1873-4995
Publication date
Advisors
Tutors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Abstract
Lipid nanoparticles (LNPs) currently dominate the RNA delivery landscape; however their limited diffusivity hampers targeted tissue dissemination, and, hence, their capacity for intracellular drug delivery. This is especially relevant for tissues such as the central nervous system (CNS), where overcoming proactive brain barriers is crucial for the efficacy of genetic therapeutics. This research aimed to create ionizable nanoemulsions (iNEs), a new generation of RNA delivery systems with enhanced diffusivity. The developed iNEs (consisting of the combination of C12–200, DOPE, Vitamin E, and DMG-PEG) with a size below 100 nm, neutral surface charge, and high RNA loading capacity, showed excellent cell viability and transfection efficiency in various cellular models, including neurons, astrocytes, and microglia. Subsequently, iNEs containing mRNA GFP were tested for CNS transfection, highlighting their exceptional diffusivity and selective transfection of neurons following intra-parenchymal administration
Description
Keywords
Bibliographic citation
Journal of Controlled Release 372 (2024) 295-303
Relation
Has part
Has version
Is based on
Is part of
Is referenced by
Is version of
Requires
Publisher version
https://doi.org/10.1016/j.jconrel.2024.06.051Sponsors
This work was supported by B-SMART project, funded by the European Union's Horizon 2020 research and innovation program under grant agreement No 721058. Authors also acknowledge the Competitive Reference Groups, Consellería de Educación e Ordenación Universitaria, Xunta de Galicia (Ref. ED431C 2021/17 and ED431C 22/41). Financial support from the Xunta de Galicia (Centro singular de Investigación de Galicia accreditation 2019-2022), the (European Union European Regional Development Fund – ERDF), and the Spanish Ministry of Science and Innovation (PID2021-126848NB-100) are gratefully acknowledged. Mireya L. Borrajo acknowledges the financial support by Instituto de Salud Carlos III through the “Contratos i-PFIS: Doctorados ISS-empresa en Ciencias y Tecnologías de la Salud” (IFI19/00033)
Rights
Atribución-NoComercial 4.0 Internacional
© 2024 The Authors. Published by Elsevier B.V. This article is available under the Creative Commons CC-BY-NC license
© 2024 The Authors. Published by Elsevier B.V. This article is available under the Creative Commons CC-BY-NC license








